National Bureau of Economic Research, Inc.
32
1
2
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 32 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
39%
11 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
The Health and Social Consequences of Depression Among the Elderly
Role: lead
The Economic Consequences of Loneliness Among the Elderly
Role: lead
Nudging Patients to Increase Shingles Vaccination
Role: collaborator
The Causal Effects of Old Age Pensions
Role: lead
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
Role: lead
High-risk Influenza Vaccine Alert
Role: collaborator
Lottery Incentive Nudges to Increase Influenza Vaccinations
Role: lead
Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot
Role: collaborator
Are Sugar-Sweetened Beverage Information Labels Well-Targeted
Role: lead
Bridging the Gap From Postpartum to Primary Care
Role: collaborator
The Impact of Group Commitment Contracts on Smoking Cessation and Weight Loss
Role: lead
COVID-19 Vaccination Take-Up
Role: lead
The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia
Role: collaborator
What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India
Role: lead
Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications
Role: collaborator
The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign
Role: lead
COVID-19 Health Messaging to Underserved Communities
Role: lead
Covid-19 Messaging to Underserved Communities - 2nd Experiment
Role: lead
Health Care Hotspotting: A Randomized Controlled Trial
Role: collaborator
Illinois Workplace Wellness Study
Role: lead